Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

HSJ-633 prevents inflammation-induced preterm birth and fetal tissue injury in vivo

March 21, 2019

OBE-022 demonstrates promising safety and PK in the first part of the PROLONG study

March 20, 2019

Millendo Therapeutics initiates pivotal phase IIb/III ZEPHYR study of livoletide

March 20, 2019

Crinetics initiates phase II program for CRN-00808 in acromegaly

March 19, 2019

How the other half controls appetite

March 19, 2019

First-in-human data presented for KL-1333

March 18, 2019

FP-101 relieves hot flashes in menopausal women and women taking tamoxifen

March 15, 2019

LRP-1 targeting confers retinal neuroprotection in diabetic mice

March 14, 2019

Discovery of the first selective inhibitor of group XVI phospholipase A2

March 14, 2019

Positive interim results reported from phase II study of NBI-74788

March 13, 2019

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...